Polygiene (POLYG) Q2 2026 earnings summary

Executive summary

• Sales increased by 3% year-over-year to SEK 32.1 million, with margin improvement to 71% from 63%.

• EBITDA turned positive at SEK 3.0 million versus SEK -1.2 million last year; EBIT at SEK 1.6 million versus SEK -2.6 million.

• Positive cash flow of SEK 6.1 million, with cash position rising to SEK 50.3 million from SEK 47.4 million.

• Strategic priorities included managing silver price volatility, innovation-driven diversification, restoring growth in the Americas, and repositioning Addmaster.

• Strategic execution continued, including pricing transition, innovation pipeline growth, and organizational changes.

Financial highlights

• Revenue rose to SEK 32.1 million from SEK 31.9 million year-over-year, with a -2% currency effect.

• Gross margin improved to 71% from 63%, aided by repricing, cost management, and a 2% positive currency effect.

• EBITDA: SEK 3.0 million (-1.2 million last year); EBIT: SEK 1.6 million (-2.6 million last year).

• Positive cash flow of SEK 6.1 million, reversing last year’s SEK -12.6 million; cash position at period end was SEK 50.3 million.

• Earnings per share: SEK 0.01 (-0.11 last year).

Outlook and guidance

• All sales from Q3 onwards will reflect the new pricing structure and higher silver costs.

• Management expects maintained gross profit in absolute terms but anticipates lower gross margin percentage due to higher sales prices from silver cost pass-through.

• Market conditions remain challenging, with recovery expected to take time and focus on disciplined execution of strategic priorities.

• Focus shifts to innovation and strategic initiatives for future growth.